Primary Site >> Esophagus Cancer
Gene >> FASLG
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. PMID: 9605174 Ref: Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. PMID: 9605741 |
Ref: Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis. PMID: 10389864 Ref: Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack. PMID: 10466039 Ref: Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. PMID: 10499620 Ref: Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan. PMID: 10520830 |
Ref: Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. PMID: 10911913 |
Ref: FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. PMID: 16186185 Ref: [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer]. PMID: 16313826 Ref: Dual effects of 8-Br-cAMP on differentiation and apoptosis of human esophageal cancer cell line Eca-109. PMID: 16425431 |
Ref: Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus. PMID: 17951168 |
Ref: Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma. PMID: 19728877 Ref: [Genetic polymorphisms in STK15 and MMP-2 associated susceptibility to esophageal cancer in Mongolian population]. PMID: 19954064 |
Ref: MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. PMID: 23504349 |
Ref: Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies. PMID: 24598538 |
Ref: Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy. PMID: 25469286 Ref: Clinicopathological significance of Fas and Fas ligand expressions in esophageal cancer. PMID: 26609492 |
Ref: Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population. PMID: 26819081 |